652 related articles for article (PubMed ID: 18383384)
1. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane.
Satoh M; Hamilton KJ; Ajmani AK; Dong X; Wang J; Kanwar YS; Reeves WH
J Immunol; 1996 Oct; 157(7):3200-6. PubMed ID: 8816434
[TBL] [Abstract][Full Text] [Related]
4. Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis.
Lech M; Skuginna V; Kulkarni OP; Gong J; Wei T; Stark RW; Garlanda C; Mantovani A; Anders HJ
J Pathol; 2010 Apr; 220(5):596-607. PubMed ID: 20112371
[TBL] [Abstract][Full Text] [Related]
5. TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy.
Summers SA; Hoi A; Steinmetz OM; O'Sullivan KM; Ooi JD; Odobasic D; Akira S; Kitching AR; Holdsworth SR
J Autoimmun; 2010 Dec; 35(4):291-8. PubMed ID: 20810248
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor engagement stimulates anti-snRNP autoreactive B cells for activation.
Ding C; Wang L; Al-Ghawi H; Marroquin J; Mamula M; Yan J
Eur J Immunol; 2006 Aug; 36(8):2013-24. PubMed ID: 16810634
[TBL] [Abstract][Full Text] [Related]
7. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
Qiao B; Wu J; Chu YW; Wang Y; Wang DP; Wu HS; Xiong SD
Rheumatology (Oxford); 2005 Sep; 44(9):1108-14. PubMed ID: 15840592
[TBL] [Abstract][Full Text] [Related]
8. Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice.
Richards HB; Satoh M; Jennette JC; Okano T; Kanwar YS; Reeves WH
Clin Exp Immunol; 1999 Mar; 115(3):547-53. PubMed ID: 10193432
[TBL] [Abstract][Full Text] [Related]
9. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
[TBL] [Abstract][Full Text] [Related]
10. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
[TBL] [Abstract][Full Text] [Related]
11. [Experimental study of pristane-induced murine lupus model].
Cui GM; Liu G; Liu W; Kan B; Mao YQ; Wei YQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):309-12. PubMed ID: 16608103
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of mast cell-deficient W/Wv mice to pristane-induced experimental lupus nephritis.
Lin L; Gerth AJ; Peng SL
Immunol Lett; 2004 Feb; 91(2-3):93-7. PubMed ID: 15019275
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.
Christensen SR; Shupe J; Nickerson K; Kashgarian M; Flavell RA; Shlomchik MJ
Immunity; 2006 Sep; 25(3):417-28. PubMed ID: 16973389
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of SmD183-119-reactive T cells that provide T cell help for pathogenic anti-double-stranded DNA antibodies.
Riemekasten G; Langnickel D; Ebling FM; Karpouzas G; Kalsi J; Herberth G; Tsao BP; Henklein P; Langer S; Burmester GR; Radbruch A; Hiepe F; Hahn BH
Arthritis Rheum; 2003 Feb; 48(2):475-85. PubMed ID: 12571858
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus.
Richards HB; Satoh M; Shaw M; Libert C; Poli V; Reeves WH
J Exp Med; 1998 Sep; 188(5):985-90. PubMed ID: 9730900
[TBL] [Abstract][Full Text] [Related]
17. Influence of antigen organization on the development of lupus autoantibodies.
Fatenejad S; Bennett M; Moslehi J; Craft J
Arthritis Rheum; 1998 Apr; 41(4):603-12. PubMed ID: 9550469
[TBL] [Abstract][Full Text] [Related]
18. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.
Santiago-Raber ML; Dunand-Sauthier I; Wu T; Li QZ; Uematsu S; Akira S; Reith W; Mohan C; Kotzin BL; Izui S
J Autoimmun; 2010 Jun; 34(4):339-48. PubMed ID: 19944565
[TBL] [Abstract][Full Text] [Related]
19. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen.
Greidinger EL; Zang Y; Jaimes K; Hogenmiller S; Nassiri M; Bejarano P; Barber GN; Hoffman RW
Arthritis Rheum; 2006 Feb; 54(2):661-9. PubMed ID: 16453294
[TBL] [Abstract][Full Text] [Related]
20. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
